Alexandria Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $930K | Hold |
4,372
| – | – | 0.09% | 150 |
|
|
2021
Q2 | $1.07M | Buy |
4,372
+3
| +0.1% | +$738 | 0.1% | 143 |
|
|
2021
Q1 | $1.09M | Hold |
4,369
| – | – | 0.11% | 141 |
|
|
2020
Q4 | $1M | Buy |
4,369
+6
| +0.1% | +$1.38K | 0.11% | 143 |
|
|
2020
Q3 | $1.11M | Hold |
4,363
| – | – | 0.13% | 135 |
|
|
2020
Q2 | $1.03M | Sell |
4,363
-26
| -0.6% | -$5.93K | 0.13% | 136 |
|
|
2020
Q1 | $890K | Sell |
4,389
-75
| -2% | -$16.4K | 0.15% | 132 |
|
|
2019
Q4 | $1.08M | Sell |
4,464
-10
| -0.2% | -$2.2K | 0.14% | 133 |
|
|
2019
Q3 | $866K | Sell |
4,474
-186
| -4% | -$35.7K | 0.13% | 142 |
|
|
2019
Q2 | $859K | Sell |
4,660
-290
| -6% | -$51.9K | 0.12% | 148 |
|
|
2019
Q1 | $940K | Sell |
4,950
-135
| -3% | -$25.8K | 0.14% | 143 |
|
|
2018
Q4 | $990K | Hold |
5,085
| – | – | 0.16% | 137 |
|
|
2018
Q3 | $1.05M | Sell |
5,085
-15
| -0.3% | -$2.96K | 0.16% | 129 |
|
|
2018
Q2 | $941K | Sell |
5,100
-250
| -5% | -$44.2K | 0.14% | 134 |
|
|
2018
Q1 | $912K | Sell |
5,350
-175
| -3% | -$32.1K | 0.14% | 137 |
|
|
2017
Q4 | $961K | Buy |
5,525
+5,090
| +1,170% | +$901K | 0.14% | 138 |
|
|
2017
Q3 | $81K | Sell |
435
-77
| -15% | -$13.6K | 0.02% | 189 |
|
|
2017
Q2 | $88K | Sell |
512
-83
| -14% | -$13.5K | 0.02% | 187 |
|
|
2017
Q1 | $98K | Buy |
595
+3
| +0.5% | +$498 | 0.02% | 179 |
|
|
2016
Q4 | $87K | Buy |
592
+10
| +2% | +$1.5K | 0.02% | 182 |
|
|
2016
Q3 | $97K | Sell |
582
-66
| -10% | -$11.2K | 0.02% | 186 |
|
|
2016
Q2 | $99K | Sell |
648
-146
| -18% | -$22.7K | 0.02% | 184 |
|
|
2016
Q1 | $119K | Buy |
794
+3
| +0.4% | +$446 | 0.02% | 179 |
|
|
2015
Q4 | $128K | Buy |
791
+2
| +0.3% | +$314 | 0.03% | 173 |
|
|
2015
Q3 | $109K | Buy |
789
+53
| +7% | +$8.35K | 0.03% | 177 |
|
|
2015
Q2 | $113K | Buy |
736
+2
| +0.3% | +$320 | 0.03% | 182 |
|
|
2015
Q1 | $117K | Buy |
734
+78
| +12% | +$12.3K | 0.04% | 147 |
|
|
2014
Q4 | $105K | Sell |
656
-174
| -21% | -$27.1K | 0.04% | 141 |
|
|
2014
Q3 | $117K | Sell |
830
-148
| -15% | -$19.3K | 0.05% | 134 |
|
|
2014
Q2 | $116K | Buy |
978
+93
| +11% | +$10.8K | 0.05% | 136 |
|
|
2014
Q1 | $109K | Buy |
885
+152
| +21% | +$18.4K | 0.05% | 136 |
|
|
2013
Q4 | $84K | Sell |
733
-221
| -23% | -$25.1K | 0.04% | 145 |
|
|
2013
Q3 | $107K | Sell |
954
-164
| -15% | -$17.8K | 0.05% | 137 |
|
|
2013
Q2 | $110K | Buy |
+1,118
| New | +$116K | 0.05% | 136 |
|
Other funds holding AMGN
Alexandria Capital's AMGN Position: Q3 2021 in Review
Alexandria Capital held its Amgen (AMGN) position steady in Q3 2021 at 4,372 shares worth $930K. The position accounts for 0.09% of the portfolio, ranked #150.
Alexandria Capital first reported a position in AMGN in Q2 2013 and has held it in 34 quarters since. The position peaked at $1.11M in Q3 2020. 2,132 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.
- Alexandria Capital held 4,372 shares of Amgen worth $930K as of Q3 2021.
- Alexandria Capital left its Amgen share count unchanged in Q3 2021.
- Amgen made up 0.09% of Alexandria Capital's portfolio in Q3 2021, its #150 holding.
- Alexandria Capital first reported a position in Amgen in Q2 2013 and has held it in 34 quarters since.
- Alexandria Capital's Amgen position peaked at $1.11M in Q3 2020.
- 2,132 funds tracked by Wall St. Rank held Amgen as of Q3 2021.
Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.